IRF7 and neoplasm: This suggests that NOS1 induction of IRF7 S-nitrosylation activates antigen-presenting cells (APCs) by increasing the transcription of MHC class I and class II antigens and APM components, thereby reversing immune suppression in the tumor microenvironment.